vesnarinone has been researched along with Brain Neoplasms in 1 studies
Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The growth and morphological change of human glioma transplanted subcutaneously and intracerebrally to nude mice with orally administered vesnarinone, 3,4-dihydro-6-[4-(3,4-dimethoxy-benzoyl)-1-piperazinyl]-2(1H)-quinolinon e, were examined." | 7.70 | Apoptosis-inducing activity and growth suppression by vesnarinone on human glioma transplanted in nude mice. ( Adachi, M; Hori, T; Kawai, K; Nakai, S; Tanaka, S, 1999) |
| "The growth and morphological change of human glioma transplanted subcutaneously and intracerebrally to nude mice with orally administered vesnarinone, 3,4-dihydro-6-[4-(3,4-dimethoxy-benzoyl)-1-piperazinyl]-2(1H)-quinolinon e, were examined." | 3.70 | Apoptosis-inducing activity and growth suppression by vesnarinone on human glioma transplanted in nude mice. ( Adachi, M; Hori, T; Kawai, K; Nakai, S; Tanaka, S, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanaka, S | 1 |
| Kawai, K | 1 |
| Nakai, S | 1 |
| Adachi, M | 1 |
| Hori, T | 1 |
1 other study available for vesnarinone and Brain Neoplasms
| Article | Year |
|---|---|
Apoptosis-inducing activity and growth suppression by vesnarinone on human glioma transplanted in nude mice.
Topics: Animals; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Dose-Response Relationship, Drug; Drug A | 1999 |